Designer drugs – A continuing chemical (R)evolution

Michael A. Taffe, Michael Olive

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalNeuropharmacology
Volume134
DOIs
StatePublished - May 15 2018

Fingerprint

Chemical Evolution
Designer Drugs

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Designer drugs – A continuing chemical (R)evolution. / Taffe, Michael A.; Olive, Michael.

In: Neuropharmacology, Vol. 134, 15.05.2018, p. 1-3.

Research output: Contribution to journalEditorial

@article{fbdac5fc60104b989367ee5c09b3bbb2,
title = "Designer drugs – A continuing chemical (R)evolution",
author = "Taffe, {Michael A.} and Michael Olive",
year = "2018",
month = "5",
day = "15",
doi = "10.1016/j.neuropharm.2018.03.037",
language = "English (US)",
volume = "134",
pages = "1--3",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Designer drugs – A continuing chemical (R)evolution

AU - Taffe, Michael A.

AU - Olive, Michael

PY - 2018/5/15

Y1 - 2018/5/15

UR - http://www.scopus.com/inward/record.url?scp=85047090035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047090035&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2018.03.037

DO - 10.1016/j.neuropharm.2018.03.037

M3 - Editorial

C2 - 29605651

AN - SCOPUS:85047090035

VL - 134

SP - 1

EP - 3

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -